Physician profile
David Reich
NPI 1922086297
$16,430.93
in general payments reported to CMS, 2019-2025
34 companies · $2,169 in 2025
The $2,169 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,818 · 2020: $1,091 · 2021: $2,328 · 2022: $2,098 · 2023: $5,261 · 2024: $1,665 · 2025: $2,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,563 · Travel and Lodging: $3,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,562.56 |
| Travel and Lodging | $3,532.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $5,080.37 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $3,692.25 | 2019-2025 | Cardiomems, Mitraclip, Amplatzer Talisman |
| Boston Scientific Corporation | $1,405.77 | 2019-2025 | Watchman Flx, Watchman Access System, Ranger |
| Medtronic, INC. | $1,225.06 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $744.81 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $633.73 | 2019-2023 | |
| Abiomed | $503.32 | 2019-2025 | Impella |
| Merck Sharp & Dohme LLC | $430.89 | 2021-2025 | Verquvo, Capvaxive |
| Kestra Medical Technology Services, INC. | $409.32 | 2023-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $299.87 | 2019-2021 | |
| Medtronic Vascular, INC. | $275.41 | 2019-2020 | |
| Stryker Corporation | $254.72 | 2025 | Flowtriever |
| E.R. Squibb & Sons, L.L.C. | $227.68 | 2021-2025 | Camzyos, Eliquis |
| Pfizer INC. | $200.75 | 2019-2025 | |
| Atricure, INC. | $115.74 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $106.23 | 2022-2025 | Repatha |
| Ekos Corporation | $96.58 | 2019 | |
| Amarin Pharma, INC. | $96.50 | 2019 | |
| Endologix LLC | $74.23 | 2025 | Endocross Device, Torus Stent Graft System |
| Daiichi Sankyo INC. | $72.23 | 2024 | Injectafer |
| Janssen Pharmaceuticals, INC | $65.77 | 2019-2023 | Xarelto |
| Penumbra, INC. | $62.13 | 2025 | Indigo System |
| Novo Nordisk INC | $60.16 | 2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.67 | 2023-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $36.07 | 2019-2025 | Wainua |
| Philips North America LLC | $35.10 | 2023 | |
| Baylis Medical Company INC | $29.85 | 2021 | |
| Cardiva Medical, INC. | $28.72 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Esperion Therapeutics, INC. | $23.76 | 2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $23.41 | 2022 | |
| Scpharmaceuticals INC. | $20.55 | 2024 | |
| Bridgebio Pharma, INC. | $20.02 | 2025 | Attruby |
| W. L. Gore & Associates, INC. | $17.87 | 2025 | Gore Cardioform Septal Occluder |
| Kiniksa Pharmaceuticals International, Plc | $17.39 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Reich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.